# HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function

> **NCT03902366** · — · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 63 (actual)

## Conditions studied

- Hepatitis C
- Alcohol Use Disorder

## Interventions

- **DIAGNOSTIC_TEST:** Neuropsychological assessment
- **BEHAVIORAL:** Neuroimaging

## Key facts

- **NCT ID:** NCT03902366
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-16
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-29
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03902366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03902366, "HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT03902366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*